Samokhvalov, Andriy V.
Levitt, Emily
MacKillop, James
Article History
Accepted: 13 February 2024
First Online: 15 March 2024
Declarations
:
: Andriy V. Samokhvalov and Emily Levitt each declare no potential conflicts of interest. James MacKillop is a principal in Beam Diagnostics, Inc., and has been a consultant to Clairvoyant Therapeutics, Inc. His contributions are supported by the Peter Boris Centre for Addictions Research, a Canada Research Chair in Translational Addiction Research (CRC-2020–00170), and a grant from the Health Canada Substance Use and Addiction Program.
: This article does not contain any studies with human or animal subjects performed by any of the authors.